Currently, the EGFR mutations among patients with NSCLC can be identified using different platforms such as direct sequencing, real-time polymerase chain reaction, or immunohistochemistry on tissue specimens obtained via image-guided invasive needle biopsies, bronchoscopy biopsies, or surgical resection [42]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.